Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Smiths medical has become aware of an issue with visible orange/brown particulate on some of hte needles of the 29g hypodermic needle-pro fixed needle insulin syringes. after a comprehensive investigation the particulate was found to consist of inorganic materials. while it is highly unlikely sensitive persons could experience a site reaction to the materials including infection or allergic reaction. smiths medical has received no reports of infection allergic reaction or injury related to this issue.